The financial year 2015/16 was brought to a successful close with further growth: Revenue increased by 4.6 percent (adjusted for currency effects: 2.7 percent) to €1,088.4m.
ZEISS continues to set the pace in OCT innovation with Swept-Source OCT imaging.
ZEISS continues to strengthen its leadership team
Introduction in the US of the VisuMax® SMILE procedure
Carl Zeiss Meditec AG is the parent company of the Carl Zeiss Meditec Group which also includes other subsidiaries. The Group is the focus for most of the medical technology business group's activity within the ZEISS organisation. The company is listed on TecDAX of the German stock exchange.
Find out more on our coporate website.
Carl Zeiss Meditec AG Website
ZEISS is one of the world’s leading suppliers of medical devices in the field of medical technology. It supplies innovative technologies and application-oriented solutions for ophthalmology and microsurgery designed to help doctors improve the quality of life of their patients.
ZEISS provides complete packages of solutions for diagnosis and devices for optical coherence tomography (OCT), perimetry, optical biometry and slit lamps. For the treatment of eye diseases ZEISS also offers not only ophthalmologic surgical microscopes, but also implants (intraocular lenses | IOLs) and consumables like ophthalmic viscosurgical devices (OVDs).
Within the field of microsurgery ZEISS creates innovative visualization solutions, especially surgical microscopes for minimally invasive surgeries. The medical technology portfolio is rounded off by promising, future-oriented technologies such as intraoperative radiotherapy.
Most of ZEISS’s medical technology activities are combined into Carl Zeiss Meditec AG, which is listed on TecDax of the German stock exchange. For more information, please click here.